chromium has been researched along with luteolin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Asha, P; Dai, J; Divya, SP; Hitron, JA; Kim, D; Pratheeshkumar, P; Roy, RV; Shi, X; Son, YO; Wang, L; Wang, Y; Zhang, Z | 1 |
Kim, D; Pratheeshkumar, P; Shi, X; Son, YO; Wang, Y; Zhang, Z | 1 |
Fiati Kenston, SS; Gu, Y; Song, X; Su, H; Wang, Y; Zhao, J | 1 |
Chen, L; Chen, Z; Ge, X; He, X; Huang, Y; Jiang, X; Lin, Z; Liu, B; Liu, T; Xu, W; Zeng, F; Zhao, C; Zhao, L; Zhu, Y | 1 |
4 other study(ies) available for chromium and luteolin
Article | Year |
---|---|
Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.
Topics: Angiogenic Proteins; Animals; Anticarcinogenic Agents; Apoptosis Regulatory Proteins; Bronchi; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Chromium; Cytoprotection; Dose-Response Relationship, Drug; Epithelial Cells; Free Radical Scavengers; Humans; Inflammation Mediators; Lung Neoplasms; Luteolin; Mice, Nude; Oxidative Stress; Potassium Dichromate; Reactive Oxygen Species; Signal Transduction; Transfection; Xenograft Model Antitumor Assays | 2014 |
Protection from Cr(VI)-induced malignant cell transformation and tumorigenesis of Cr(VI)-transformed cells by luteolin through Nrf2 signaling.
Topics: Carcinogenesis; Carcinogens, Environmental; Cell Line; Cell Transformation, Neoplastic; Chromium; Cytoprotection; Dose-Response Relationship, Drug; Humans; Luteolin; NF-E2-Related Factor 2; Signal Transduction | 2017 |
Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosis through downregulation of ROS-activated mitochondrial pathway.
Topics: Apoptosis; Cadmium; Caspase 3; Caspase 9; Cell Line; Cell Survival; China; Chromium; Copper; Gene Expression Regulation; Humans; Lead; Luteolin; Manganese; Membrane Potential, Mitochondrial; Mercury; Metals, Heavy; Mitochondria; Nickel; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Signal Transduction; Zinc | 2018 |
6,8-(1,3-Diaminoguanidine) luteolin and its Cr complex show hypoglycemic activities and alter intestinal microbiota composition in type 2 diabetes mice.
Topics: Animals; Chromium; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome; Glycogen Synthase Kinase 3 beta; Guanidines; Hypoglycemic Agents; Luteolin; Mice; Organometallic Compounds; Phosphatidylinositol 3-Kinases | 2022 |